Pharmacology
 |
|
23 may 2022 18:57:21 |
| [ASAP] PET Imaging of Bromodomain and Extra-Terminal Domain Inhibitors for the Noninvasive Assessment of Metabolic Changes in the Liver and Brain of Early-Stage Alcoholic Liver Disease (Molecular Pharmaceutics) |
|
Tweet Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00143 |
| 147 viewsCategory: Pharmacology |
 [ASAP] In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil (Molecular Pharmaceutics)[ASAP] Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach (Molecular Pharmaceutics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
